Research use only.  Educational reference. Not medical advice. Not for human consumption.
⚙️ Mitochondrial-Targeted Peptide

SS-31 (Elamipretide) Dosage Protocols: All Vial Sizes

SS-31 (elamipretide) is a mitochondrial-targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane, stabilizing electron-transport chain function. Choose your vial size below; each size has its own exact dosing table.

Choose Your Vial Size

VialFinal volumeConcentrationOne U-100 unit
10 mg1 mL10 mg/mL100 mcg in 0.01 mLOpen protocol →
50 mg3 mL16.67 mg/mL166.67 mcg in 0.01 mLOpen protocol →

Doses are the same research amounts across sizes; the vial size changes the concentration, so syringe units differ. Always use the table for your exact vial.

Storage Instructions

StateTemperatureDuration
Lyophilized−20°C (−4°F)Up to 24 months, dry & dark
Reconstituted2–8°C (35–46°F)Up to 28 days, protect from light

Important Notes

⚠ Research Use Only: SS-31/elamipretide has multiple Phase 2/3 trials. Use outside trials is research-grade.

How This Works

SS-31 is a synthetic tetrapeptide (D-Arg-2',6'-dimethylTyr-Lys-Phe-NH2) of the Szeto-Schiller class. Its alternating cationic-aromatic structure concentrates it in the inner mitochondrial membrane (1000–5000× more than cytoplasm). It binds cardiolipin — the unique phospholipid that organizes the electron-transport chain — preserving cristae structure and ATP synthesis under oxidative stress.

Potential Benefits & Side Effects

Potential Benefits

Side Effect Profile

Lifestyle Factors

Injection Technique

References

1
Birk AV et al. 'SS-31 and ischemic mitochondria' — J Am Soc Nephrol, 2013 View source ↗
2
Karaa A et al. 'Elamipretide in primary mitochondrial myopathy' — Neurology, 2018 View source ↗